A controversial theory holds that one immunization, given properly, can protect against many diseases besides its target
Clinical-trial participants and their carers are gaining influence over how experiments are run. As they take to social media, that could make things messy for the science
In the past, measles outbreaks have been brought under control with vaccines, but the dynamic may be shifting
Republican efforts to dismantle U.S. health care unfairly target one gender
In his memoirs, the womanizing writer Giacomo Casanova described suffering several bouts of gonorrhea—but researchers found no trace of the microbe on his handwritten journals. Karen Hopkin reports...
Experts caution that addressing lingering questions will require more research.
Applying network theory to HIV’s structure has revealed the most valuable—and vulnerable—parts of the virus
Is a runaway immune reaction making a dengue vaccine dangerous?
The surge in cases has sent 66 children to the hospital, according to the Centers for Disease Control and Prevention
The vaccine is up to 40 percent effective at preventing malaria in young children
U.S. agencies warn doctors not to abruptly cut off the medications for long-time users
One in three gluten-free dishes tested at restaurants contained gluten—especially GF pizzas and pastas. Christopher Intagliata reports.
An experimental drug for hepatitis D triggers a cellular waste disposal system to rid mice brains of the tau protein, a major culprit in neurodegenerative disease
Trial failure raises doubts about amyloid as a target for drug development
Propofol reduces the intensity of traumatic memories
The new drug, Zulresso, can work in days, not the weeks it takes for current treatments
Medical researcher Steffanie Strathdee needed to save the life of her husband, researcher Tom Patterson, when he contracted one of the world's worst infections. She turned to phage therapy: using a virus to kill the bacteria...
Thyroid hormone, which helps warm-blooded animals regulate body temperature, also appears to put a halt on heart regeneration. Christopher Intagliata reports.
Nasal spray related to the anesthetic/street drug ketamine targets treatment-resistant patients
10 years after the so-called “Berlin Patient,” a second man has been put into sustained remission